Inactive Instrument

Sector Chart Clarus Therapeutics Holdings, Inc.

Equities

CRXT

US18271L1070

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
693B
584B
372B
332B
294B